Bone Biologics Corp Common Stock

BBLGNASDAQ • USD
ThemeMedical Devices & HealthTech›Orthopedic & Implantable Devices
1.25 USD
↘ 0.00 (0.10%)AT CLOSE (11:59 AM EDT)
1.24
↘ 0.00 (0.30%)
POST MARKET (AS OF 06:54 PM EDT)
Post Market
AS OF 06:54 PM EDT
1.24
↘ 0.00 (0.30%)
🔴Market: CLOSED
Open?$1.25
High?$1.27
Low?$1.23
Prev. Close?$1.25
Volume?16.9K
Avg. Volume?13.0K
VWAP?$1.25
Rel. Volume?1.30x
Bid / Ask
Bid?$1.21 × 1.1K
Ask?$1.24 × 400
Spread?$0.03
Midpoint?$1.23
Valuation & Ratios
Market Cap?2.2M
Shares Out?1.8M
Float?1.7M
Float %?94.4%
P/E Ratio?N/A
P/B Ratio?0.48
EPS?-$1.59
Dividend?0.00%
Ex-Dividend?N/A

BBLG is currently priced at $1.25. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, BBLG appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
Themes
Medical Devices & HealthTech›Orthopedic & Implantable Devices
Employees
2
Market Cap
2.2M
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Website
www.bonebiologics.com
Listed
2015-11-27
Address
2 BURLINGTON WOODS DRIVE,
BURLINGTON, MA 01803
Phone: (781) 552-4452
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-21.56Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.17%Low
Short Interest?2.9K
Days to Cover?1.0
Free Float1.7M
Avg Daily Volume9.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?15.42Strong
Quick Ratio?15.42Strong
Cash Ratio?14.64Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.48CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-61.2%WEAK▾
ROA?
S&P
3
-57.4%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-2285965
Fundamentals ratios updated end of day
MarketsMoversWatchlist